Lataa...
IL-2-driven CD8(+) T cell phenotypes: implications for immunotherapy
The therapeutic potential of interleukin (IL)-2 in cancer treatment has been known for decades, yet its widespread adoption in clinical practice remains limited. Recently, chimeric proteins of an anti-PD-1 antibody and suboptimal IL-2 variants were shown to stimulate potent antitumor and antiviral i...
Tallennettuna:
| Julkaisussa: | Trends Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2023
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615502/ https://ncbi.nlm.nih.gov/pubmed/37827864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2023.09.003 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|